Table 2.
Clinical results of motility enhancers for sperm recovery by TESE.
Compound | Control | Results | Refs. |
---|---|---|---|
Pentoxifylline | Hypoosmotic test | Increased fertilization rate (62% vs. 41% p < 0.05) Increased pregnancy rate (32% vs. 16% p < 0.05) |
[53] |
Pentoxifylline | Untreated immotile sperm | Initiated motility in 95.7% of the samples. Increased fertilization rate (66% vs. 50.9%; p < 0.005) Increased mean number of embryos per cycle (4.7 vs. 2.7 p < 0.01). |
[55] |
Pentoxifylline | In-group | Induced additional motility in 33.3% and 69.3% of cases where fresh and frozen samples were used, respectively. | [57] |
Pentoxifylline | Untreated immotile sperm | Initiated motility in 70.8% of the samples. | [42] |
Theophylline | Untreated motile or immotile sperm | Improved motility in 98.5% of the cases. Increased fertilization (79.9% vs. 63.3% p < 0.001) and pregnancy (53.9% vs. 23.8% p < 0.05) rates. |
[45] |